rs8178216
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_006904.7(PRKDC):c.9601C>T(p.Pro3201Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00962 in 1,605,872 control chromosomes in the GnomAD database, including 92 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006904.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKDC | NM_006904.7 | c.9601C>T | p.Pro3201Ser | missense_variant | 69/86 | ENST00000314191.7 | NP_008835.5 | |
PRKDC | NM_001081640.2 | c.9601C>T | p.Pro3201Ser | missense_variant | 69/85 | NP_001075109.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKDC | ENST00000314191.7 | c.9601C>T | p.Pro3201Ser | missense_variant | 69/86 | 1 | NM_006904.7 | ENSP00000313420.3 |
Frequencies
GnomAD3 genomes AF: 0.00710 AC: 1080AN: 152126Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00647 AC: 1575AN: 243262Hom.: 11 AF XY: 0.00652 AC XY: 861AN XY: 132042
GnomAD4 exome AF: 0.00989 AC: 14370AN: 1453628Hom.: 89 Cov.: 30 AF XY: 0.00954 AC XY: 6897AN XY: 722662
GnomAD4 genome AF: 0.00709 AC: 1080AN: 152244Hom.: 3 Cov.: 32 AF XY: 0.00690 AC XY: 514AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 13, 2022 | Variant summary: PRKDC c.9598C>T (p.Pro3200Ser) (refseq HGVS c.9601C>T, p.Pro3201Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0065 in 243262 control chromosomes in the gnomAD database, including 11 homozygotes. The observed variant frequency is approximately 18 fold of the estimated maximal expected allele frequency for a pathogenic variant in PRKDC causing Severe Combined Immunodeficiency phenotype (0.00035), strongly suggesting that the variant is benign. To our knowledge, no penetrant association or occurrence of c.9598C>T in individuals affected with Severe Combined Immunodeficiency (specifically Immunodeficiency 26, with or without neurologic abnormalities, OMIM 60089) and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PRKDC: BP4, BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 07, 2018 | This variant is associated with the following publications: (PMID: 24476948) - |
Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at